Mohamad Bydon, M.D. | UChicago Neurosurgery

About Dr. Bydon

Dr. Bydon is one of the most published spine surgeons in the country, with over 700 peer-reviewed manuscripts. He launched one of the nation's first robotic and minimally invasive spine surgery programs. His stem cell trial — the first-in-human study of stem cell therapy for spinal cord injury — showed that 7 of 10 paralyzed patients regained neurological function, published in Nature Communications (2024). He holds 12 medical device patents and runs the Section of Computational Neuroscience at UChicago, using AI and machine learning to predict surgical outcomes at national scale.

Education & Training

B.A., Dartmouth College
M.D., Yale School of Medicine
Residency, Neurosurgery, Johns Hopkins Hospital
Fellowship, Complex Spine & Spinal Oncology, Johns Hopkins

National Leadership

Editor-in-Chief, International Journal of Neuroscience
Editorial Board, Journal of Neurosurgery
Spine Committee, Congress of Neurological Surgeons
55 national & international scientific awards

Selected Publications

Bydon M, et al. Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial. Nature Communications. 2024. PMID: 38561341

Bydon M, et al. First report from a Phase 1 trial of autologous adipose tissue-derived mesenchymal stem cells in the treatment of paralysis. Mayo Clin Proc. 2020. PMID: 31785831